Linden, a Chicago-based healthcare focused private equity firm, has completed fundraising for Linden Capital Partners II, which closed with USD375m of committed capital and exceeded its target of USD300m and initial cap of USD350m. Linden’s second fund continues the strategy from its first fund, executed through industry specialisation in healthcare

ClearBridge Energy MLP Fund has raised approximately USD1.268bn in its common stock offering, assuming full exercise of the underwriters’ overallotment option. Its shares have begun trading today on the New York Stock Exchange under the symbol CEM. The fund’s investment objective is to provide a high level of total return

YRC Worldwide has entered into a definitive agreement to sell a portion of its YRC Logistics business to Austin Ventures, a private equity investor. This logistics business will operate as a private company owned by Austin Ventures. The sale will form the basis for a new company specialising in international

Origo Partners has made an investment of up to USD6.65m for a 20 per cent equity stake in Jinan Eco-Energy Technology, a Chinese provider and operator of recycling systems for waste plastic and scrap-tyres. This investment represents the third in a series of shortlisted investment opportunities for which Origo raised

Investment and advisory firm Manfield Partners has acquired WaverleyTBS, a supplier to the on-trade drinks sector, from Heineken UK. WaverleyTBS supplies 31,000 national and independent free trade outlets throughout the UK. It supplies a full of range beer, cider, spirits, wine and soft drinks. The company generated GBP500m of sales

DFJ Mercury, a seed and early-stage venture capital firm investing in IT, advanced materials, and bioscience companies, had closed DFJ Mercury Fund II with USD70m in total commitments.  As part of Fund II, several new institutional investors joined the support already provided by DFJ Mercury Fund I’s high-net-worth and family

Kneip, a service provider to the asset management industry, has repurchased all shares held by private equity firm 3i, following strong growth for the group during the last three years. 3i first invested for a significant minority stake in Kneip during May 2007 to help increase the company’s service offering

RoundTable Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, has made a controlling investment in Aqua Pharmaceuticals. Founded in 2004, Aqua is a dermatology pharmaceutical company focused on acquiring, developing and marketing under-promoted, branded, pharmaceutical products in the US. Financial terms of the transaction were not

Albion Ventures has invested GBP2.65m in Masters Pharmaceuticals as sole investor. Masters is a supplier and distributor of pharmaceutical products. The investment will be used for continued expansion in its core markets of Latin America, the Middle East and the Caribbean. Masters is also seeking to open new markets in